Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Oncological treatment and outcome of colorectal cancer in Greenland

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. No association between early maternal HbA1c and offspring birthweight among women without pre-existing diabetes in Greenland

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Diabetes in Greenland - how to deliver diabetes care in a country with a geographically dispersed population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Gestational diabetes and macrosomia among Greenlanders. Time to change diagnostic strategy?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Gonorrhoea in Greenland: geographic differences in diagnostic activity and incidence of gonorrhoea in 2015

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Regional variation in out-of-hospital cardiac arrest: incidence and survival - a nationwide study of regions in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The clinical use of hyperbaric oxygen in the treatment of Danish patients with diabetic foot ulcers

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Short-stay unit hospitalisation vs. standard care outcomes in older internal medicine patients-a randomised clinical trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Endoscopic electrochemotherapy for esophageal cancer: a phase I clinical study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Oncological treatment of colorectal cancer (CRC) has been available in Greenland since 2004. Treatment is provided by Queen Ingrid´s Hospital (QIH), under supervision from the Department of Oncology, Rigshospitalet, Denmark. The study describes patient characteristics, oncological treatment and survival for the first 8 years of treatment. The study was a registry-based observational study of all patients in Greenland diagnosed with histologically verified CRC from August 2004 to August 2012. Analyses were stratified according to stage and discussed in relation to reported data from patients with CRC in Denmark. 180 patients were included. . Stage I, II, III, and IV comprised 15, 34, 23, and 23%, respectively. 5% presented with unknown stage. A total of 51% received oncological treatment. 79% of patients with Stage III disease received adjuvant chemotherapy, 61% of patients with metastatic CRC received palliative chemotherapy. Five-year survival was 48 and 53% for colon and rectum cancer, respectively. An insignificant trend towards higher survival in men than in women was seen; adjusted hazard ratio for death (women vs men) = 1.46 (95% CI = 0.97-2.19). In conclusion; Stage distribution, provision of oncological treatment and 5-year survival were comparable to patients diagnosed and treated in Denmark.

OriginalsprogEngelsk
TidsskriftInternational Journal of Circumpolar Health
Vol/bind77
Udgave nummer1
Sider (fra-til)1546069
ISSN1239-9736
DOI
StatusUdgivet - 2018

ID: 55670832